Kaldor Stephen W 4/A
4/A · Furiex Pharmaceuticals, Inc. · Filed Mar 14, 2013
Insider Transaction Report
Form 4/AAmended
Kaldor Stephen W
Director
Transactions
- Exercise/Conversion
Common Stock
2013-03-12$13.94/sh+973$13,564→ 973 total - Sale
Common Stock
2013-03-12$40.71/sh−973$39,611→ 0 total - Exercise/Conversion
Common Stock
2013-03-13$13.94/sh+1,648$22,973→ 1,648 total - Sale
Common Stock
2013-03-13$39.96/sh−1,648$65,854→ 0 total - Exercise/Conversion
Stock Options (to buy)
2013-03-11−5,379→ 7,633 totalExercise: $13.94Exp: 2021-05-19→ Common Stock (5,379 underlying) - Exercise/Conversion
Stock Options (to buy)
2013-03-13−1,648→ 5,012 totalExercise: $13.94Exp: 2021-05-19→ Common Stock (1,648 underlying) - Sale
Common Stock
2013-03-11$41.74/sh−5,379$224,519→ 0 total - Exercise/Conversion
Stock Options (to buy)
2013-03-12−973→ 6,660 totalExercise: $13.94Exp: 2021-05-19→ Common Stock (973 underlying) - Exercise/Conversion
Common Stock
2013-03-11$13.94/sh+5,379$74,983→ 5,379 total
Holdings
- 8,825
Stock Options (to buy)
Exercise: $13.45Exp: 2021-10-12→ Common Stock (8,825 underlying) - 17,500
Stock Options (to buy)
Exercise: $18.22Exp: 2022-05-24→ Common Stock (17,500 underlying)
Footnotes (5)
- [F1]These options and underlying shares were previously incorrectly reported as 8,000 in the Form 4.
- [F2]This exercise of options was previously incorrectly reported as being included in the 8,000 referenced in footnote (1).
- [F3]The options were awarded on 5/19/2011 and vest and become exercisable in full on the earlier of the first anniversary of the date of grant or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.
- [F4]The options were awarded on 10/12/2011 and vest and become exercisable in full on the earlier of 5/19/2012 or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.
- [F5]The options were awarded on 5/24/2012 and vest and become exercisable in full on the earlier of 5/24/2013 or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.